ARCHIVES

Aflibercept-Docetaxel Combination Misses Primary Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: Daniel Nixon Of Emory to Head Prevention Program; Henderson To Get Rosenthal Award

January 30, 1987

ACS Research Grants Hit $78.2 Million

July 18, 1986

National Cancer Institute Lists Approved Clinical Trials

January 31, 2003

In Brief: Cooperative Group Investigators Treat 10 For Every Patient In Protocols – Holland

October 31, 1975

Program Announcement: Breast Cancer Research

May 28, 1993

NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement

March 18, 1994